Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Got $1,000? 2 Incredible Growth Stocks to Buy and Hold Forever


Growth stocks aren't created equal, but great businesses can stand the test of time in a portfolio and reward shareholders many times over through the years. Healthcare stocks with strong business profiles, robust revenue growth, and healthy profits can offer greater reliability through various market cycles.

No industry is totally impervious to market dynamics, but healthcare companies as a whole are broadly more resilient in difficult times given the essential needs they serve for patients and customers. If you're looking for growth-oriented healthcare stocks to add to your portfolio right now, here are two names you won't want to miss.

Vertex Pharmaceuticals (NASDAQ: VRTX) has had a banner year so far. It launched the world's first CRISPR therapy (a potential one-time functional cure for two rare blood disorders) and is experiencing steady growth from an existing portfolio of market-leading medicines. If you're not familiar with this company, it's the leader in the cystic fibrosis therapeutics market and is the only one that has drugs approved to treat the root cause of this genetic disease.

Continue reading


Source Fool.com

Vertex Pharmaceuticals Inc. Aktie

453,20 €
-3,26 %
Die Vertex Pharmaceuticals Inc. Aktie verzeichnet heute einen großen Rückgang um -3,26 %.
Hohe Buy- und niedrige Sell-Zahlen bei Vertex Pharmaceuticals Inc. zeigen ein stark positives Sentiment.
Ein unerwartetes negatives Potenzial von -0.71% für Vertex Pharmaceuticals Inc., trotz eines niedrigeren Kursziels von 450 € als der aktuelle Kurs von 453.2 €.
Like: 0
Teilen

Kommentare